Tech Base/Enabling Rsrch for Infect Dis Adv Tech
Abstract
Technology development, demonstration, and transition of FDA-regulated medical countermeasures such as drugs and vaccines to naturally-occurring infectious diseases of military importance, as identified by worldwide medical surveillance and capability needs assessments. Research is conducted in compliance with FDA regulations for medical products for human use. Work is managed by the United States Army Medical Research and Materiel Command (USAMRMC) in coordination with the Naval Medical Research Center (NMRC). The Army is responsible for programming and funding all Department of Defense (DoD) naturally occurring infectious disease research requirements, thereby precluding duplication of effort within the Military Departments. Promising medical countermeasures identified in this Project are further matured under Program Element 0603807A, Project 808. The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. All FY20 adjustments align program resources to Army Modernization Priorities in support of the National Defense Strategy. Work in this Project is performed by: the U.S. Army Medical Research Materiel Command (USAMRMC), Fort Detrick, MD. Efforts in this Project support the Soldier portfolio and the principal area of Military Relevant Infectious Diseases.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2020
- Source ID
- MM9_0603002A_3_2040_PB_2020
Related Documents
- Root: Medical Advanced Technology
- Child Accomplishment: Advanced Technology Research on drugs and vaccines against parasitic diseases
- Child Accomplishment: Viral Disease Threats